Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-07-28 16:31:45
Reporting Period:
Filing Date:
Accepted Time:
2017-07-28 16:31:45
Original Submission Date:
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1300699 Athenex Inc. ATNX Pharmaceutical Preparations (2834) 431985966
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1316746 Nick J Riehle C/o Athenex, Inc.,
1001 Main Street, Suite 600
Buffalo NY 14203
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-19 1,500 $11.00 1,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. These shares of Common Stock ("Shares") were inadvertently omitted from the Reporting Person's Form 4 filed June 21, 2017.
  2. These Shares were purchased in the Issuer's initial public offering, which closed on June 19, 2017.